Loading…

Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC)

Saved in:
Bibliographic Details
Published in:European urology open science (Online) 2020-07, Vol.19, p.e1844-e1845
Main Authors: Thomsen, L.C.V., Honoré, A., Almås, B., Reisæter, L.A.R., Førde, K., Kristoffersen, E.K., Kaada, S.H., Melve, G.K., Helle, S.I., Kvalheim, G., Azeem, W., Olsen, J.R., Halvorsen, O.J., Akslen, L.A., Bahn, D., Pantel, K., Riethdorf, S., Ragde, H., Gjertsen, B.T., Øyan, A.M., Kalland, K.H., Beisland, C.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2666-1683
2666-1683
DOI:10.1016/S2666-1683(20)33842-8